1. Home
  2. DAIO vs RNAZ Comparison

DAIO vs RNAZ Comparison

Compare DAIO & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data I/O Corporation

DAIO

Data I/O Corporation

SELL

Current Price

$2.62

Market Cap

26.2M

Sector

Industrials

ML Signal

SELL

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

HOLD

Current Price

$1.04

Market Cap

27.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAIO
RNAZ
Founded
1969
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.2M
27.9M
IPO Year
2026
2021

Fundamental Metrics

Financial Performance
Metric
DAIO
RNAZ
Price
$2.62
$1.04
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 28.4K
19.2K
Earning Date
11-12-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $21,500,000.00
N/A
Revenue This Year
$3.26
N/A
Revenue Next Year
$25.00
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.16
$1.28
52 Week High
$4.49
$12.60

Technical Indicators

Market Signals
Indicator
DAIO
RNAZ
Relative Strength Index (RSI) 49.79 25.80
Support Level $2.28 N/A
Resistance Level $2.73 $1.93
Average True Range (ATR) 0.17 0.16
MACD 0.03 -0.02
Stochastic Oscillator 58.33 6.42

Price Performance

Historical Comparison
DAIO
RNAZ

About DAIO Data I/O Corporation

Data I/O Corp provides semiconductor programming, security provisioning, and intellectual property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It operates as a single segment entity, with the sole objective to design, manufacture, and sell programming solutions and Programming-as-a-Service (PaaS) to the world's various electronics manufacturers including OEMs, CMs and EMS companies. The company operate in three separate locations Redmond, Washington; Shanghai, China; and Munich, Germany.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: